New patent notice for GTC Biotherapeutics

FRAMINGHAM, MA - GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for the claims in its patent application 07/938,322 covering the production of therapeutic proteins in the milk of transgenic mammals. The allowed claims, which are expected to issue in the next several weeks, include all classes of proteins in all mammals and will provide GTC with a strong intellectual property position regarding the development and use of this technology for US markets. The patent that is expected to issue from this application will not expire until 2021. "Source":[ http://www.checkbiotech.org/root/index.cfm?fuseaction=subtopics&topic_id=1&subtopic_id=4&doc_id=11986&start=1&control=407&page_start=1&page_nr=151&pg=1]

---